| 2024-12-02 | +0.19 % |
|
| 2024-11-29 | -0.32 % |
|
| 2024-11-25 | -0.06 % |
|
| 2024-11-19 | -1.42 % |
|
| 2024-11-13 | +1.47 % |
|
| 2024-11-08 | +1.98 % |
|
| 2024-11-06 | +2.12 % |
- Cardinal Health (CAH) stock rose 2.12% following positive earnings results that exceeded analyst expectations and an increase in price targets from multiple brokerage firms, indicating strong investor confidence.
- Cardinal Health (CAH) stock rose by 2.12% following the announcement of raised price targets from several brokerages, including Deutsche Bank's increase from $119.00 to $124.00, signaling optimism about the company's performance despite a mixed earnings report.
- Cardinal Health (CAH) stock rose by 2.12% following investment analysts at Mizuho raising its price target from $110.00 to $120.00, indicating potential upside, along with positive earnings results that exceeded expectations.
- Cardinal Health's stock (CAH) rose by 2.12% after positive quarterly earnings, where it beat analysts’ expectations, coupled with several analysts raising their price targets, indicating favorable investor sentiment and confidence in the company's performance.
- Cardinal Health (CAH) stock rose 2.12% after Barclays raised its price target from $117.00 to $133.00, indicating substantial upside potential, along with positive earnings results that exceeded analysts' expectations.
|
| 2024-11-01 | +7.01 % |
|
| 2024-10-31 | +0.58 % |
|
| 2024-10-30 | -1.97 % |
|
| 2024-10-29 | -0.73 % |
|
| 2024-10-28 | -0.02 % |
|
| 2024-10-24 | +0.21 % |
|
| 2024-10-23 | -0.28 % |
|
| 2024-10-18 | +0.43 % |
|
| 2024-10-16 | +0.51 % |
|
| 2024-10-15 | +0.05 % |
|
| 2024-10-14 | -0.52 % |
|
| 2024-10-11 | -1.17 % |
|
| 2024-10-10 | -0.61 % |
|
| 2024-10-09 | +1.7 % |
|
| 2024-10-07 | -0.2 % |
|
| 2024-10-03 | +0.13 % |
|
| 2024-09-27 | +0.51 % |
|
| 2024-09-26 | +0.38 % |
|
| 2024-09-25 | -1.24 % |
|
| 2024-09-24 | -1.48 % |
|
| 2024-09-04 | -0.65 % |
|
| 2024-08-14 | +3.68 % |
- Cardinal Health (CAH) stock rose by 3.68% due to the company's stronger-than-expected profit report for the spring, aligning with a generally positive market reaction to inflation data that suggested potential interest rate cuts by the Federal Reserve.
- Cardinal Health (CAH) stock experienced a 3.68% increase, primarily driven by positive momentum in the broader market and an optimistic outlook for the U.S. economy, leading to increased investor confidence.
- Cardinal Health (CAH) stock rose 3.68% following the company's better-than-expected financial results and an increase in guidance, driven by strong drug sales.
- Cardinal Health Inc. (NYSE: CAH) experienced a 3.68% stock increase following its impressive fourth-quarter and fiscal year 2024 earnings report, which highlighted a 29% rise in earnings per share and a revenue growth of 12%, alongside an upward revision of its fiscal year 2025 guidance, reflecting strong financial performance and confidence in future growth prospects. The stock rose due to the company's robust financial results, strategic investments, and improved outlook which resonate positively with investors, indicating potential for continued value creation.
- Cardinal Health's stock rose by 5.2% after the company raised its 2025 profit forecast, reflecting positive investor sentiment in response to its improved outlook amidst a broader market reaction to slowing inflation in the US.
|
| 2024-08-09 | +1.77 % |
|
| 2024-08-08 | -0.79 % |
|
| 2024-06-14 | -0.41 % |
|
| 2024-06-12 | +0.16 % |
|
| 2024-06-11 | +0.17 % |
|
| 2024-06-07 | -0.29 % |
|
| 2024-06-06 | +0.86 % |
|
